Skip to main content
Journal cover image
Pharmacotherapy of Child and Adolescent Psychiatric Disorders: Third Edition

Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders

Publication ,  Chapter
Heleniak, CM; Kaur, T; Ghalib, KD; Rynn, MA
February 17, 2012

Tricyclic Antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs) remain useful pharmacotherapies for pediatric psychiatric disorders despite the fact that they are no longer used as first line medications. In pediatric populations, evidence supports the use of TCAs as second or third line treatment for several disorders including OCD, ADHD, and some pain disorders. While less evidence supports the use of MAOIs in youth, the selegiline transdermal patch is currently under investigation and may provide a viable alternative for the treatment of pediatric psychiatric illness. This chapter describes the chemical properties, indications, treatment guidelines, and side effect profiles of both TCAs and MAOIs in the treatment of children and adolescents. © 2012 John Wiley & Sons, Ltd.

Duke Scholars

DOI

ISBN

9780470973769

Publication Date

February 17, 2012

Start / End Page

105 / 129
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Heleniak, C. M., Kaur, T., Ghalib, K. D., & Rynn, M. A. (2012). Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders. In Pharmacotherapy of Child and Adolescent Psychiatric Disorders: Third Edition (pp. 105–129). https://doi.org/10.1002/9781119958338.ch7
Heleniak, C. M., T. Kaur, K. D. Ghalib, and M. A. Rynn. “Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders.” In Pharmacotherapy of Child and Adolescent Psychiatric Disorders: Third Edition, 105–29, 2012. https://doi.org/10.1002/9781119958338.ch7.
Heleniak CM, Kaur T, Ghalib KD, Rynn MA. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders. In: Pharmacotherapy of Child and Adolescent Psychiatric Disorders: Third Edition. 2012. p. 105–29.
Heleniak, C. M., et al. “Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders.” Pharmacotherapy of Child and Adolescent Psychiatric Disorders: Third Edition, 2012, pp. 105–29. Scopus, doi:10.1002/9781119958338.ch7.
Heleniak CM, Kaur T, Ghalib KD, Rynn MA. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders. Pharmacotherapy of Child and Adolescent Psychiatric Disorders: Third Edition. 2012. p. 105–129.
Journal cover image

DOI

ISBN

9780470973769

Publication Date

February 17, 2012

Start / End Page

105 / 129